SCHEMBL4670779

SCHEMBL4670779

CC(C(=O)NO)N(Cc1ccccc1)S(=O)(=O)N1CCN(c2ccc(Cl)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 12/20 0.51
▸ RORB Q92753 1/20 0.51
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ MMP1 P03956 1/20 0.48
▸ MMP2 P08253 1/20 0.48
▸ MMP9 P14780 1/20 0.48
▸ MMP8 P22894 1/20 0.48
▸ MMP13 P45452 1/20 0.48
▸ CCR1 P32246 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ MMP14 P50281 1/20 0.43
▸ ADAMTS5 Q9UNA0 1/20 0.43
▸ DRD2 P14416 1/20 0.42
▸ DRD4 P21917 1/20 0.42
▸ DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4670781 1.00 RORC (0.51) RORCRORBMEN1KMT2ACA1
SCHEMBL8111325 0.90 MEN1 (0.52) RORCRORBMEN1KMT2ACCR1
SCHEMBL8111326 0.90 MEN1 (0.52) RORCRORBMEN1KMT2ACCR1
SCHEMBL4675059 0.88 RORC (0.48) RORCRORBMEN1KMT2ACCR1
SCHEMBL4675062 0.88 RORC (0.48) RORCRORBMEN1KMT2ACCR1
SCHEMBL4673369 0.72 MMP2 (0.60) RORCRORBCA1CA2MMP1
SCHEMBL4673376 0.72 MMP2 (0.60) RORCRORBCA1CA2MMP1
SCHEMBL4674851 0.72 MMP1 (0.57) MEN1KMT2AMMP1MMP2MMP9
SCHEMBL4674856 0.72 MMP1 (0.57) MEN1KMT2AMMP1MMP2MMP9
SCHEMBL7324705 0.72 MEN1 (0.49) MEN1KMT2AMMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 — — EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 — — EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 — — US disclosed
US-6143744-A Sulfamide-metalloprotease inhibitors SYNTEX (U.S.A.) INC. (US) 2000-11-07 — — US disclosed
US-6130220-A ENZYME INHIBITORS SYNTEX (USA) INC. (US) 2000-10-10 — — US disclosed
US-5998412-A ANTIARTHRITIC AGENTS; OSTEOPOROSIS SYNTEX (U.S.A.) INC. (US) 1999-12-07 — — US disclosed
Send feedback